What is the recommended sweep speed for a Pulmonary Artery Catheter (PAC) in a critically ill patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PAC Sweep Speed

I cannot provide a recommendation on sweep speed for pulmonary artery catheter monitoring because none of the provided evidence addresses sweep speed settings for PAC waveform display.

What the Evidence Actually Covers

The available guidelines and research discuss:

  • PAC placement indications and timing - The ASA recommends PAC placement before anesthesia induction in cardiogenic shock patients, and considers it reasonable for acute hemodynamic instability 1

  • Infection prevention and catheter duration - The CDC states PAC can remain in place without routine replacement for at least 7 days, with heparin-bonded catheters showing lower infection rates (2.6 vs 5.5 per 1,000 catheter days) 1

  • Hemodynamic parameters and interpretation - Normal values include PA systolic pressure 15-30 mmHg, diastolic 4-12 mmHg, and PCWP <12 mmHg 2

  • Complications - Major complications include arrhythmias, PA rupture (0.03-0.2% incidence with 41-70% mortality), and catheter-related infections 1, 3

The Missing Information

Sweep speed refers to the horizontal time scale on the monitor display (typically 25 mm/sec or 50 mm/sec for cardiac waveforms), which affects how waveforms appear on screen and in printouts. This technical display parameter is not addressed in any of the clinical guidelines or research provided 1, 2.

Standard practice typically uses 25 mm/sec for routine hemodynamic monitoring to allow adequate waveform visualization, but this represents general medical knowledge rather than evidence-based guidance from the provided sources.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pulmonary Artery Catheter Monitoring Parameters and Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Complications associated with pulmonary artery catheters: a comprehensive clinical review.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society, 2009

Related Questions

What parameters are measured by a Pulmonary Artery Catheter (PAC) in critically ill patients?
Does a Pulmonary Artery Catheter (PAC) have continuous fluid running through it?
What is the best monitoring strategy to detect unintentional continuous wedging in a patient with a Pulmonary Artery Catheter (PAC) in place?
When is a pulmonary artery (PA) catheter indicated for surgery?
Is the use of a pulmonary artery (PA) catheter recommended in patients with severe mitral regurgitation, severe tricuspid regurgitation, and severe pulmonary arterial hypertension?
Is having four consecutive children of the same sex (i.e. four girls or four boys) uncommon?
Why is the P (P wave) wave inverted in lead aVR (augmented limb lead) on an electrocardiogram (ECG)?
What is the diagnosis and treatment for a 54-year-old non-hypertensive female with diabetic ketoacidosis (DKA), status post (s/p) cardiac arrest (CP arrest) with 3 minutes of downtime, who became hypotensive, has progressive deterioration of level of consciousness, multiple intracerebral hemorrhages on cranial computed tomography (CT) scan, severe thrombocytopenia (platelet count of 18), impaired renal function (elevated creatinine), and hypernatremia (elevated sodium)?
Is it rare for a family to have four consecutive female children?
What is the significance of P wave inversion in lead aVR (electrocardiogram lead) in patients with potential cardiovascular disease?
What to add to telmisartan (Angiotensin II Receptor Antagonist) 40mg, cilnidipine (Calcium Channel Blocker) 10mg, and chlorthalidone (Thiazide-like Diuretic) 12.5mg twice daily for a young male patient with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and normal renal function, who still has uncontrolled hypertension (>140/90 mmHg)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.